Form 4: Guardant Health Director's RSU Vesting Reported

Guardant Health Director Steve Krognes reported the vesting of 154 restricted stock units, converting them into common stock.

Summary

• Director Steve E. Krognes reported a transaction involving Guardant Health, Inc. common stock and restricted stock units.
• On January 31, 2026, 154 restricted stock units (RSUs) vested and were converted into 154 shares of common stock.
• The RSUs had a conversion/exercise price of $0, indicating they were part of an equity compensation plan.
• Following this transaction, Krognes directly beneficially owns 18,899 shares of common stock and 772 restricted stock units.
• The original RSU award was granted on August 9, 2022, with 25% vesting on June 30, 2023, and the remaining 75% vesting monthly over three years from June 30, 2023.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents routine equity compensation vesting, reinforcing director alignment with shareholder interests without indicating new strategic developments.

Positives

• Vesting of restricted stock units indicates continued equity participation and alignment of interests between the director and shareholders.
• The director's beneficial ownership of 18,899 common shares and 772 RSUs demonstrates a significant stake in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly the vesting of equity awards, are common occurrences in publicly traded companies. This specific transaction reflects a routine part of executive and director compensation structures, aligning insider interests with long-term company performance.

Stakeholder Impact

• Shareholders: The vesting and conversion of RSUs into common stock increases the director's direct ownership, potentially strengthening alignment with shareholder interests.
• Employees (specifically the director): This transaction represents a realization of a portion of the director's equity compensation.

Next Steps

• Remaining 75% of the RSU award will continue to vest in substantially equal installments on each monthly anniversary of June 30, 2023, for the three-year period thereafter.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of restricted stock units for a director. Such transactions are part of standard equity compensation and do not typically signal a change in the company's fundamental outlook or warrant a strong buy/sell recommendation. It reinforces insider alignment but provides no new material information to alter an investment thesis, hence a 'hold' is appropriate for existing positions.

Keywords

Guardant Health, GH, Steve Krognes, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Compensation, Equity Compensation